{"transactions":[{"id":736062,"issuer":{"id":1562,"kind":"organization","name":"Travere Therapeutics, Inc.","symbol":"TVTX"},"owners":[{"id":37659,"kind":"person","name":"Coughlin Timothy","position":1,"cik":"0001376043","reported_name":"Coughlin Timothy","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-06-16T20:46:48.000Z","date":"2026-06-12","kind":"exercise","planned":true,"acquired":false,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The stock option is fully vested and exercisable."}],"balance_after":0,"derivative":{"exercise_price":26.52,"expiration_date":"2028-05-08","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001376043-26-000010","document":"form4-06162026_080644.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1438533/000137604326000010/form4-06162026_080644.xml","form_type":"4"}},{"id":736061,"issuer":{"id":1562,"kind":"organization","name":"Travere Therapeutics, Inc.","symbol":"TVTX"},"owners":[{"id":37659,"kind":"person","name":"Coughlin Timothy","position":1,"cik":"0001376043","reported_name":"Coughlin Timothy","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-06-16T20:46:48.000Z","date":"2026-06-12","kind":"sale","planned":true,"acquired":false,"shares":10000,"price":50.0747,"value":500747.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This sale was made pursuant to a written plan adopted on November 19, 2025, meeting the requirements of Rule 10b5-1(c) of the Securities Exchange Act of 1934, as amended."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The weighted average sale price for the transaction reported was $50.0747, and the range of prices were between $50.00 and $50.32. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each price will be provided."}],"balance_after":56250,"source":{"system":"sec-edgar","filing":"0001376043-26-000010","document":"form4-06162026_080644.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1438533/000137604326000010/form4-06162026_080644.xml","form_type":"4"}},{"id":736060,"issuer":{"id":1562,"kind":"organization","name":"Travere Therapeutics, Inc.","symbol":"TVTX"},"owners":[{"id":37659,"kind":"person","name":"Coughlin Timothy","position":1,"cik":"0001376043","reported_name":"Coughlin Timothy","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-06-16T20:46:48.000Z","date":"2026-06-12","kind":"exercise","planned":true,"acquired":true,"shares":10000,"price":26.52,"value":265200.0,"ownership":{"direct":true},"balance_after":66250,"source":{"system":"sec-edgar","filing":"0001376043-26-000010","document":"form4-06162026_080644.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1438533/000137604326000010/form4-06162026_080644.xml","form_type":"4"}},{"id":743205,"issuer":{"id":4522,"kind":"organization","name":"Vir Biotechnology, Inc.","symbol":"VIR"},"owners":[{"id":37659,"kind":"person","name":"Coughlin Timothy","position":1,"cik":"0001376043","reported_name":"Coughlin Timothy","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock  Option  (Right  to Buy)","published_at":"2026-06-10T22:21:32.000Z","date":"2026-06-09","kind":"grant","planned":false,"acquired":true,"shares":16000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The shares subject to the stock option vest and become exercisable  in full on the earlier of (i) June 9, 2027, or (ii) the date of the Issuer's next annual meeting of stockholders."}],"balance_after":16000,"derivative":{"exercise_price":8.51,"expiration_date":"2036-06-08","underlying":"Common Stock","underlying_shares":16000},"source":{"system":"sec-edgar","filing":"0001628280-26-042326","document":"wk-form4_1781130089.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1706431/000162828026042326/wk-form4_1781130089.xml","form_type":"4"}},{"id":743204,"issuer":{"id":4522,"kind":"organization","name":"Vir Biotechnology, Inc.","symbol":"VIR"},"owners":[{"id":37659,"kind":"person","name":"Coughlin Timothy","position":1,"cik":"0001376043","reported_name":"Coughlin Timothy","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock  Option  (Right  to Buy)","published_at":"2026-06-10T22:21:32.000Z","date":"2026-06-09","kind":"grant","planned":false,"acquired":true,"shares":16000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"1/3 of the shares subject to the stock option will vest and become exercisable on June 9, 2027, and the remaining shares will vest and become exercisable in 24 equal monthly installments thereafter."}],"balance_after":16000,"derivative":{"exercise_price":8.51,"expiration_date":"2036-06-08","underlying":"Common  Stock","underlying_shares":16000},"source":{"system":"sec-edgar","filing":"0001628280-26-042326","document":"wk-form4_1781130089.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1706431/000162828026042326/wk-form4_1781130089.xml","form_type":"4"}},{"id":743203,"issuer":{"id":4522,"kind":"organization","name":"Vir Biotechnology, Inc.","symbol":"VIR"},"owners":[{"id":37659,"kind":"person","name":"Coughlin Timothy","position":1,"cik":"0001376043","reported_name":"Coughlin Timothy","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common  Stock","published_at":"2026-06-10T22:21:32.000Z","date":"2026-06-09","kind":"grant","planned":false,"acquired":true,"shares":8000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Acquisition of restricted stock units (RSUs) pursuant to the Issuer's Equity Incentive Plan."},{"field":"shares","element":"transactionShares","label":"F3","text":"The RSUs will vest in full on the earlier of (i) June 9, 2027, or (ii) the date of the Issuer's next annual meeting of stockholders."}],"balance_after":16000,"source":{"system":"sec-edgar","filing":"0001628280-26-042326","document":"wk-form4_1781130089.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1706431/000162828026042326/wk-form4_1781130089.xml","form_type":"4"}},{"id":743202,"issuer":{"id":4522,"kind":"organization","name":"Vir Biotechnology, Inc.","symbol":"VIR"},"owners":[{"id":37659,"kind":"person","name":"Coughlin Timothy","position":1,"cik":"0001376043","reported_name":"Coughlin Timothy","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common  Stock","published_at":"2026-06-10T22:21:32.000Z","date":"2026-06-09","kind":"grant","planned":false,"acquired":true,"shares":8000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Acquisition of restricted stock units (RSUs) pursuant to the Issuer's Equity Incentive Plan."},{"field":"shares","element":"transactionShares","label":"F2","text":"1/3 of the RSUs will vest on June 9, 2027, and the remaining RSUs will vest in two equal annual installments thereafter."}],"balance_after":8000,"source":{"system":"sec-edgar","filing":"0001628280-26-042326","document":"wk-form4_1781130089.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1706431/000162828026042326/wk-form4_1781130089.xml","form_type":"4"}},{"id":751143,"issuer":{"id":6502,"kind":"organization","name":"ADC Therapeutics SA"},"owners":[{"id":37659,"kind":"person","name":"Coughlin Timothy","position":1,"cik":"0001376043","reported_name":"Coughlin Timothy","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Shares","published_at":"2026-06-03T21:02:03.000Z","date":"2026-06-03","kind":"tax_withholding","planned":false,"acquired":false,"shares":12600,"price":3.08,"value":38808.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Represents the number of Common Shares withheld by the Issuer to satisfy the Reporting Person's tax withholding obligations in connection with the vesting of restricted share units previously granted."}],"balance_after":72400,"source":{"system":"sec-edgar","filing":"0001628280-26-040487","document":"wk-form4_1780520520.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1376043/000162828026040487/wk-form4_1780520520.xml","form_type":"4"}},{"id":751142,"issuer":{"id":6502,"kind":"organization","name":"ADC Therapeutics SA"},"owners":[{"id":37659,"kind":"person","name":"Coughlin Timothy","position":1,"cik":"0001376043","reported_name":"Coughlin Timothy","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Shares","published_at":"2026-06-03T21:02:03.000Z","date":"2026-06-01","kind":"grant","planned":false,"acquired":true,"shares":45000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the annual grant of restricted stock units (\"RSUs\") made under the Issuer's 2019 Equity Incentive Plan for service as a Director. The RSUs vest on the earlier of (i) one year from the grant date or (ii) the date of the 2027 Annual Meeting of Shareholders, subject to the Reporting Person's continued service to the Issuer.  Each RSU represents a contingent right to receive one share of the Issuer's common stock."}],"balance_after":85000,"source":{"system":"sec-edgar","filing":"0001628280-26-040487","document":"wk-form4_1780520520.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1376043/000162828026040487/wk-form4_1780520520.xml","form_type":"4"}},{"id":767806,"issuer":{"id":1562,"kind":"organization","name":"Travere Therapeutics, Inc.","symbol":"TVTX"},"owners":[{"id":37659,"kind":"person","name":"Coughlin Timothy","position":1,"cik":"0001376043","reported_name":"Coughlin Timothy","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock option (right to buy)","published_at":"2026-05-21T21:00:10.000Z","date":"2026-05-19","kind":"grant","planned":false,"acquired":true,"shares":12000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Automatic equity grant under the Issuer's 2018 Equity Incentive Plan, as amended, pursuant to the non-employee director compensation program."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The equity award vests over a one year period."}],"balance_after":12000,"derivative":{"exercise_price":42.26,"exercise_date":"2027-05-19","expiration_date":"2036-05-19","underlying":"Common Stock","underlying_shares":12000},"source":{"system":"sec-edgar","filing":"0001376043-26-000006","document":"form4-05212026_050506.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1438533/000137604326000006/form4-05212026_050506.xml","form_type":"4"}},{"id":767805,"issuer":{"id":1562,"kind":"organization","name":"Travere Therapeutics, Inc.","symbol":"TVTX"},"owners":[{"id":37659,"kind":"person","name":"Coughlin Timothy","position":1,"cik":"0001376043","reported_name":"Coughlin Timothy","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-05-21T21:00:10.000Z","date":"2026-05-19","kind":"grant","planned":false,"acquired":true,"shares":4000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Automatic equity grant under the Issuer's 2018 Equity Incentive Plan, as amended, pursuant to the non-employee director compensation program."},{"field":"shares","element":"transactionShares","label":"F2","text":"The equity award vests over a one year period."}],"balance_after":56250,"source":{"system":"sec-edgar","filing":"0001376043-26-000006","document":"form4-05212026_050506.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1438533/000137604326000006/form4-05212026_050506.xml","form_type":"4"}},{"id":771853,"issuer":{"id":1562,"kind":"organization","name":"Travere Therapeutics, Inc.","symbol":"TVTX"},"owners":[{"id":37659,"kind":"person","name":"Coughlin Timothy","position":1,"cik":"0001376043","reported_name":"Coughlin Timothy","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-05-19T20:05:08.000Z","date":"2026-05-15","kind":"sale","planned":true,"acquired":false,"shares":3250,"price":43.49,"value":141342.5,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This sale was made pursuant to a written plan adopted on November 19, 2025, meeting the requirements of Rule 10b5-1(c) of the Securities Exchange Act of 1934, as amended."}],"balance_after":52250,"source":{"system":"sec-edgar","filing":"0001376043-26-000005","document":"form4-05192026_040501.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1438533/000137604326000005/form4-05192026_040501.xml","form_type":"4"}},{"id":780531,"issuer":{"id":7233,"kind":"organization","name":"aTYR PHARMA INC"},"owners":[{"id":37659,"kind":"person","name":"Coughlin Timothy","position":1,"cik":"0001376043","reported_name":"Coughlin Timothy","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2026-05-13T20:17:25.000Z","date":"2026-05-11","kind":"grant","planned":false,"acquired":true,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option, granted pursuant to the Issuer's non-employee director compensation policy, vests in full on the earlier of (i) May 11, 2027 or (ii) the Issuer's 2027 Annual Meeting of Stockholders, subject to the Reporting Person's continued service on the Board of Directors."}],"balance_after":50000,"derivative":{"exercise_price":0.95,"expiration_date":"2036-05-11","underlying":"Common Stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0001376043-26-000003","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1339970/000137604326000003/ownership.xml","form_type":"4"}},{"id":1008081,"issuer":{"id":1562,"kind":"organization","name":"Travere Therapeutics, Inc.","symbol":"TVTX"},"owners":[{"id":37659,"kind":"person","name":"Coughlin Timothy","position":1,"cik":"0001376043","reported_name":"Coughlin Timothy","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Director stock option (right to buy)","published_at":"2025-11-04T21:05:13.000Z","date":"2025-10-31","kind":"exercise","planned":true,"acquired":false,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The stock option is fully vested and exercisable."}],"balance_after":0,"derivative":{"exercise_price":17.44,"expiration_date":"2027-05-16","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001376043-25-000004","document":"form4-11042025_041110.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1438533/000137604325000004/form4-11042025_041110.xml","form_type":"4"}},{"id":1008080,"issuer":{"id":1562,"kind":"organization","name":"Travere Therapeutics, Inc.","symbol":"TVTX"},"owners":[{"id":37659,"kind":"person","name":"Coughlin Timothy","position":1,"cik":"0001376043","reported_name":"Coughlin Timothy","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Director stock option (right to buy)","published_at":"2025-11-04T21:05:13.000Z","date":"2025-10-31","kind":"exercise","planned":true,"acquired":false,"shares":8000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The stock option is fully vested and exercisable."}],"balance_after":0,"derivative":{"exercise_price":16.33,"expiration_date":"2026-05-17","underlying":"Common Stock","underlying_shares":8000},"source":{"system":"sec-edgar","filing":"0001376043-25-000004","document":"form4-11042025_041110.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1438533/000137604325000004/form4-11042025_041110.xml","form_type":"4"}},{"id":1008079,"issuer":{"id":1562,"kind":"organization","name":"Travere Therapeutics, Inc.","symbol":"TVTX"},"owners":[{"id":37659,"kind":"person","name":"Coughlin Timothy","position":1,"cik":"0001376043","reported_name":"Coughlin Timothy","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-11-04T21:05:13.000Z","date":"2025-10-31","kind":"sale","planned":true,"acquired":false,"shares":18000,"price":35.0334,"value":630601.2,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This sale was made pursuant to a written plan adopted on June 16, 2025, meeting the requirements of Rule 10b5-1(c) of the Securities Exchange Act of 1934, as amended."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The weighted average sale price for the transaction reported was $35.0334, and the range of prices were between $35.00 and $35.15. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each price will be provided."}],"balance_after":55500,"source":{"system":"sec-edgar","filing":"0001376043-25-000004","document":"form4-11042025_041110.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1438533/000137604325000004/form4-11042025_041110.xml","form_type":"4"}},{"id":1008078,"issuer":{"id":1562,"kind":"organization","name":"Travere Therapeutics, Inc.","symbol":"TVTX"},"owners":[{"id":37659,"kind":"person","name":"Coughlin Timothy","position":1,"cik":"0001376043","reported_name":"Coughlin Timothy","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-11-04T21:05:13.000Z","date":"2025-10-31","kind":"exercise","planned":true,"acquired":true,"shares":10000,"price":17.44,"value":174400.0,"ownership":{"direct":true},"balance_after":73500,"source":{"system":"sec-edgar","filing":"0001376043-25-000004","document":"form4-11042025_041110.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1438533/000137604325000004/form4-11042025_041110.xml","form_type":"4"}},{"id":1008077,"issuer":{"id":1562,"kind":"organization","name":"Travere Therapeutics, Inc.","symbol":"TVTX"},"owners":[{"id":37659,"kind":"person","name":"Coughlin Timothy","position":1,"cik":"0001376043","reported_name":"Coughlin Timothy","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-11-04T21:05:13.000Z","date":"2025-10-31","kind":"exercise","planned":true,"acquired":true,"shares":8000,"price":16.33,"value":130640.0,"ownership":{"direct":true},"balance_after":63500,"source":{"system":"sec-edgar","filing":"0001376043-25-000004","document":"form4-11042025_041110.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1438533/000137604325000004/form4-11042025_041110.xml","form_type":"4"}},{"id":1120991,"issuer":{"id":6502,"kind":"organization","name":"ADC Therapeutics SA"},"owners":[{"id":37659,"kind":"person","name":"Coughlin Timothy","position":1,"cik":"0001376043","reported_name":"COUGHLIN TIMOTHY","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options (Right to Buy)","published_at":"2025-06-05T21:13:04.000Z","date":"2025-06-03","kind":"grant","planned":false,"acquired":true,"shares":80000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Represents a one-time initial stock option award made under the Issuer's 2019 Equity Incentive Plan. The options vest over four years from June 3, 2025, with 1/4 vesting on the first anniversary of such date, and the remainder vesting monthly in 36 equal installments, subject to continued service through each such vesting date."}],"balance_after":80000,"derivative":{"exercise_price":3.59,"expiration_date":"2035-06-05","underlying":"Common Shares","underlying_shares":80000},"source":{"system":"sec-edgar","filing":"0001628280-25-029742","document":"wk-form4_1749157954.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1376043/000162828025029742/wk-form4_1749157954.xml","form_type":"4"}},{"id":1120990,"issuer":{"id":6502,"kind":"organization","name":"ADC Therapeutics SA"},"owners":[{"id":37659,"kind":"person","name":"Coughlin Timothy","position":1,"cik":"0001376043","reported_name":"COUGHLIN TIMOTHY","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Shares","published_at":"2025-06-05T21:13:04.000Z","date":"2025-06-03","kind":"grant","planned":false,"acquired":true,"shares":40000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the annual grant of restricted stock units (\"RSUs\") made under the Issuer's 2019 Equity Incentive Plan for service as a Director. The RSUs vest one year from the grant date, subject to the Reporting Person's continued service to the Issuer. Each RSU represents a contingent right to receive one share of the Issuer's common stock."}],"balance_after":40000,"source":{"system":"sec-edgar","filing":"0001628280-25-029742","document":"wk-form4_1749157954.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1376043/000162828025029742/wk-form4_1749157954.xml","form_type":"4"}},{"id":1145192,"issuer":{"id":1562,"kind":"organization","name":"Travere Therapeutics, Inc.","symbol":"TVTX"},"owners":[{"id":37659,"kind":"person","name":"Coughlin Timothy","position":1,"cik":"0001376043","reported_name":"COUGHLIN TIMOTHY","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock option (right to buy)","published_at":"2025-05-16T23:00:10.000Z","date":"2025-05-15","kind":"grant","planned":false,"acquired":true,"shares":19500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Automatic equity grant under the Issuer's 2018 Equity Incentive Plan, as amended, pursuant to the non-employee director compensation program."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The equity award vests over a one year period."}],"balance_after":19500,"derivative":{"exercise_price":21.15,"exercise_date":"2026-05-15","expiration_date":"2035-05-15","underlying":"Common Stock","underlying_shares":19500},"source":{"system":"sec-edgar","filing":"0001415889-25-013498","document":"form4-05162025_070507.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1438533/000141588925013498/form4-05162025_070507.xml","form_type":"4"}},{"id":1145191,"issuer":{"id":1562,"kind":"organization","name":"Travere Therapeutics, Inc.","symbol":"TVTX"},"owners":[{"id":37659,"kind":"person","name":"Coughlin Timothy","position":1,"cik":"0001376043","reported_name":"COUGHLIN TIMOTHY","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-05-16T23:00:10.000Z","date":"2025-05-15","kind":"grant","planned":false,"acquired":true,"shares":6500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Automatic equity grant under the Issuer's 2018 Equity Incentive Plan, as amended, pursuant to the non-employee director compensation program."},{"field":"shares","element":"transactionShares","label":"F2","text":"The equity award vests over a one year period."}],"balance_after":55500,"source":{"system":"sec-edgar","filing":"0001415889-25-013498","document":"form4-05162025_070507.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1438533/000141588925013498/form4-05162025_070507.xml","form_type":"4"}},{"id":1160840,"issuer":{"id":7233,"kind":"organization","name":"aTYR PHARMA INC"},"owners":[{"id":37659,"kind":"person","name":"Coughlin Timothy","position":1,"cik":"0001376043","reported_name":"COUGHLIN TIMOTHY","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2025-05-02T21:16:28.000Z","date":"2025-05-01","kind":"grant","planned":false,"acquired":true,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option, granted pursuant to the Issuer's non-employee director compensation policy, vests in full on the earlier of (i) May 1, 2026 or (ii) the Issuer's 2026 Annual Meeting of Stockholders, subject to the Reporting Person's continued service on the Board of Directors."}],"balance_after":50000,"derivative":{"exercise_price":3.34,"expiration_date":"2035-05-01","underlying":"Common Stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0000950170-25-062932","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1339970/000095017025062932/ownership.xml","form_type":"4"}},{"id":1483333,"issuer":{"id":5968,"kind":"organization","name":"FATE THERAPEUTICS INC"},"owners":[{"id":37659,"kind":"person","name":"Coughlin Timothy","position":1,"cik":"0001376043","reported_name":"COUGHLIN TIMOTHY","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2024-06-11T20:29:36.000Z","date":"2024-06-07","kind":"grant","planned":false,"acquired":true,"shares":40000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction represents a grant of options pursuant to the terms of the Issuer's Amended and Restated Non-Employee Director Compensation Policy which provides for annual equity grants to the Issuer's non-employee directors on the date of the Issuer's Annual Meeting of Stockholders."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares subject to this option shall vest and become exercisable on the earlier of (i) June 7, 2025 or (ii) the date of the Issuer's 2025 Annual Meeting of Stockholders, subject to the Reporting Person's continued service on the Issuer's Board of Directors."}],"balance_after":40000,"derivative":{"exercise_price":3.68,"expiration_date":"2034-06-07","underlying":"Common Stock","underlying_shares":40000},"source":{"system":"sec-edgar","filing":"0000950170-24-071950","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1434316/000095017024071950/ownership.xml","form_type":"4"}},{"id":1494885,"issuer":{"id":7233,"kind":"organization","name":"aTYR PHARMA INC"},"owners":[{"id":37659,"kind":"person","name":"Coughlin Timothy","position":1,"cik":"0001376043","reported_name":"COUGHLIN TIMOTHY","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-06-03T20:21:12.000Z","date":"2024-05-30","kind":"purchase","planned":false,"acquired":true,"shares":50000,"price":1.75,"value":87500.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents weighted average price for the shares. The shares were purchased at prices ranging from $1.665 to $1.80 per share. The reporting person will provide to the Securities and Exchange Commission staff, the issuer, or any security holder of the issuer, upon request, full information regarding the number of shares purchased at each separate price."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"These shares are owned by the Coughlin Family Trust u/a DTD 12/07/2006. The Reporting Person and his spouse serve as co-trustees of the Coughlin Family Trust u/a DTD 12/07/2006. The Reporting Person may be deemed to be the beneficial owner of the securities held by the Coughlin Family Trust u/a DTD 12/07/2006."}],"balance_after":56000,"source":{"system":"sec-edgar","filing":"0000950170-24-067989","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1339970/000095017024067989/ownership.xml","form_type":"4"}},{"id":1503374,"issuer":{"id":7233,"kind":"organization","name":"aTYR PHARMA INC"},"owners":[{"id":37659,"kind":"person","name":"Coughlin Timothy","position":1,"cik":"0001376043","reported_name":"COUGHLIN TIMOTHY","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2024-05-23T23:07:42.000Z","date":"2024-05-22","kind":"grant","planned":false,"acquired":true,"shares":24000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option, granted pursuant to the Issuer's non-employee director compensation policy, vests in full on the earlier of (i) May 22, 2025 or (ii) the Issuer's 2025 Annual Meeting of Stockholders, subject to the Reporting Person's continued service on the Board of Directors."}],"balance_after":24000,"derivative":{"exercise_price":1.86,"expiration_date":"2034-05-22","underlying":"Common Stock","underlying_shares":24000},"source":{"system":"sec-edgar","filing":"0000950170-24-064199","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1339970/000095017024064199/ownership.xml","form_type":"4"}},{"id":1520560,"issuer":{"id":1562,"kind":"organization","name":"Travere Therapeutics, Inc.","symbol":"TVTX"},"owners":[{"id":37659,"kind":"person","name":"Coughlin Timothy","position":1,"cik":"0001376043","reported_name":"COUGHLIN TIMOTHY","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock option (right to buy)","published_at":"2024-05-10T20:05:39.000Z","date":"2024-05-08","kind":"grant","planned":false,"acquired":true,"shares":19500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Automatic equity grant under the Issuer's 2018 Equity Incentive Plan, as amended, pursuant to the non-employee director compensation program."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The equity award vests over a one year period."}],"balance_after":19500,"derivative":{"exercise_price":6.82,"exercise_date":"2025-05-08","expiration_date":"2034-05-07","underlying":"Common Stock","underlying_shares":19500},"source":{"system":"sec-edgar","filing":"0001415889-24-012846","document":"form4-05102024_040522.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1438533/000141588924012846/form4-05102024_040522.xml","form_type":"4"}},{"id":1520559,"issuer":{"id":1562,"kind":"organization","name":"Travere Therapeutics, Inc.","symbol":"TVTX"},"owners":[{"id":37659,"kind":"person","name":"Coughlin Timothy","position":1,"cik":"0001376043","reported_name":"COUGHLIN TIMOTHY","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-05-10T20:05:39.000Z","date":"2024-05-08","kind":"grant","planned":false,"acquired":true,"shares":6500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Automatic equity grant under the Issuer's 2018 Equity Incentive Plan, as amended, pursuant to the non-employee director compensation program."},{"field":"shares","element":"transactionShares","label":"F2","text":"The equity award vests over a one year period."}],"balance_after":49000,"source":{"system":"sec-edgar","filing":"0001415889-24-012846","document":"form4-05102024_040522.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1438533/000141588924012846/form4-05102024_040522.xml","form_type":"4"}},{"id":1863770,"issuer":{"id":5968,"kind":"organization","name":"FATE THERAPEUTICS INC"},"owners":[{"id":37659,"kind":"person","name":"Coughlin Timothy","position":1,"cik":"0001376043","reported_name":"COUGHLIN TIMOTHY","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2023-06-07T20:06:14.000Z","date":"2023-06-06","kind":"grant","planned":false,"acquired":true,"shares":40000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction represents a grant of options pursuant to the terms of the Issuer's Amended and Restated Non-Employee Director Compensation Policy which provides for annual equity grants to the Issuer's non-employee directors on the date of the Issuer's Annual Meeting of Stockholders."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares subject to this option shall vest and become exercisable on the earlier of (i) June 6, 2024 or (ii) the date of the Issuer's 2024 Annual Meeting of Stockholders, subject to the Reporting Person's continued service on the Issuer's Board of Directors."}],"balance_after":40000,"derivative":{"exercise_price":5.52,"expiration_date":"2033-06-06","underlying":"Common Stock","underlying_shares":40000},"source":{"system":"sec-edgar","filing":"0001209191-23-035044","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1434316/000120919123035044/doc4.xml","form_type":"4"}},{"id":1884224,"issuer":{"id":7233,"kind":"organization","name":"aTYR PHARMA INC"},"owners":[{"id":37659,"kind":"person","name":"Coughlin Timothy","position":1,"cik":"0001376043","reported_name":"COUGHLIN TIMOTHY","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2023-05-19T20:27:18.000Z","date":"2023-05-17","kind":"grant","planned":false,"acquired":true,"shares":12000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option, granted pursuant to the Issuer's non-employee director compensation policy, vests in full on the earlier of (i) May 17, 2024 or (ii) the Issuer's 2024 Annual Meeting of Stockholders, subject to the Reporting Person's continued service on the Board of Directors."}],"balance_after":12000,"derivative":{"exercise_price":2.52,"expiration_date":"2033-05-17","underlying":"Common Stock","underlying_shares":12000},"source":{"system":"sec-edgar","filing":"0001209191-23-031008","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1339970/000120919123031008/doc4.xml","form_type":"4"}},{"id":1884223,"issuer":{"id":7233,"kind":"organization","name":"aTYR PHARMA INC"},"owners":[{"id":37659,"kind":"person","name":"Coughlin Timothy","position":1,"cik":"0001376043","reported_name":"COUGHLIN TIMOTHY","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-05-19T20:27:18.000Z","date":"2023-05-17","kind":"gift","planned":false,"acquired":true,"shares":6000,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"These shares are owned by the Coughlin Family Trust u/a DTD 12/07/2006. The Reporting Person and his spouse serve as co-trustees of the Coughlin Family Trust u/a DTD 12/07/2006. The Reporting Person may be deemed to be the beneficial owner of the securities held by the Coughlin Family Trust u/a DTD 12/07/2006."}],"balance_after":6000,"source":{"system":"sec-edgar","filing":"0001209191-23-031008","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1339970/000120919123031008/doc4.xml","form_type":"4"}},{"id":1884222,"issuer":{"id":7233,"kind":"organization","name":"aTYR PHARMA INC"},"owners":[{"id":37659,"kind":"person","name":"Coughlin Timothy","position":1,"cik":"0001376043","reported_name":"COUGHLIN TIMOTHY","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-05-19T20:27:18.000Z","date":"2023-05-17","kind":"gift","planned":false,"acquired":false,"shares":6000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":0,"source":{"system":"sec-edgar","filing":"0001209191-23-031008","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1339970/000120919123031008/doc4.xml","form_type":"4"}},{"id":1884448,"issuer":{"id":1562,"kind":"organization","name":"Travere Therapeutics, Inc.","symbol":"TVTX"},"owners":[{"id":37659,"kind":"person","name":"Coughlin Timothy","position":1,"cik":"0001376043","reported_name":"COUGHLIN TIMOTHY","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock option (right to buy)","published_at":"2023-05-19T20:05:59.000Z","date":"2023-05-17","kind":"grant","planned":false,"acquired":true,"shares":13500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Automatic equity grant under the Issuer's 2018 Equity Incentive Plan, as amended, pursuant to the non-employee director compensation program."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The equity award vests over a one year period."}],"balance_after":13500,"derivative":{"exercise_price":17.11,"exercise_date":"2024-05-17","expiration_date":"2033-05-16","underlying":"Common Stock","underlying_shares":13500},"source":{"system":"sec-edgar","filing":"0001209191-23-030958","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1438533/000120919123030958/doc4.xml","form_type":"4"}},{"id":1884447,"issuer":{"id":1562,"kind":"organization","name":"Travere Therapeutics, Inc.","symbol":"TVTX"},"owners":[{"id":37659,"kind":"person","name":"Coughlin Timothy","position":1,"cik":"0001376043","reported_name":"COUGHLIN TIMOTHY","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-05-19T20:05:59.000Z","date":"2023-05-17","kind":"grant","planned":false,"acquired":true,"shares":4500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Automatic equity grant under the Issuer's 2018 Equity Incentive Plan, as amended, pursuant to the non-employee director compensation program."},{"field":"shares","element":"transactionShares","label":"F2","text":"The equity award vests over a one year period."}],"balance_after":42500,"source":{"system":"sec-edgar","filing":"0001209191-23-030958","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1438533/000120919123030958/doc4.xml","form_type":"4"}},{"id":1911194,"issuer":{"id":7233,"kind":"organization","name":"aTYR PHARMA INC"},"owners":[{"id":37659,"kind":"person","name":"Coughlin Timothy","position":1,"cik":"0001376043","reported_name":"COUGHLIN TIMOTHY","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Unit","published_at":"2023-04-28T20:51:36.000Z","date":"2023-04-26","kind":"exercise","planned":false,"acquired":false,"shares":6000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"RSUs convert into common stock on a one-for-one basis."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The RSUs fully vested one year from the grant date which was April 26, 2022."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The RSUs fully vested one year from the grant date which was April 26, 2022."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":6000},"source":{"system":"sec-edgar","filing":"0001209191-23-026062","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1339970/000120919123026062/doc4.xml","form_type":"4"}},{"id":1911193,"issuer":{"id":7233,"kind":"organization","name":"aTYR PHARMA INC"},"owners":[{"id":37659,"kind":"person","name":"Coughlin Timothy","position":1,"cik":"0001376043","reported_name":"COUGHLIN TIMOTHY","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common stock","published_at":"2023-04-28T20:51:36.000Z","date":"2023-04-26","kind":"exercise","planned":false,"acquired":true,"shares":6000,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares acquired upon the vesting of restricted stock units (RSUs) granted to the Reporting Person on April 26, 2022."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"RSUs convert into common stock on a one-for-one basis."}],"balance_after":6000,"source":{"system":"sec-edgar","filing":"0001209191-23-026062","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1339970/000120919123026062/doc4.xml","form_type":"4"}},{"id":2234029,"issuer":{"id":5968,"kind":"organization","name":"FATE THERAPEUTICS INC"},"owners":[{"id":37659,"kind":"person","name":"Coughlin Timothy","position":1,"cik":"0001376043","reported_name":"COUGHLIN TIMOTHY","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2022-06-13T20:39:42.000Z","date":"2022-06-09","kind":"grant","acquired":true,"shares":11893,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The shares subject to this option shall vest and become exercisable on the earlier of (i) June 9, 2023 or (ii) the date of the Issuer's 2023 Annual Meeting of Stockholders, subject to the Reporting Person's continued service on the Issuer's Board of Directors."}],"balance_after":11893,"derivative":{"exercise_price":23.48,"expiration_date":"2032-06-09","underlying":"Common Stock","underlying_shares":11893},"source":{"system":"sec-edgar","filing":"0001209191-22-036343","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1434316/000120919122036343/doc4.xml","form_type":"4"}},{"id":2234028,"issuer":{"id":5968,"kind":"organization","name":"FATE THERAPEUTICS INC"},"owners":[{"id":37659,"kind":"person","name":"Coughlin Timothy","position":1,"cik":"0001376043","reported_name":"COUGHLIN TIMOTHY","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-06-13T20:39:42.000Z","date":"2022-06-09","kind":"grant","acquired":true,"shares":8650,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Award of restricted stock units that vest in full on the earlier of (i) June 9, 2023 or (ii) the date of the Issuer's 2023 Annual Meeting of Stockholders, subject to the Reporting Person's continued service on the Issuer's Board of Directors."}],"balance_after":9892,"source":{"system":"sec-edgar","filing":"0001209191-22-036343","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1434316/000120919122036343/doc4.xml","form_type":"4"}},{"id":2242204,"issuer":{"id":5968,"kind":"organization","name":"FATE THERAPEUTICS INC"},"owners":[{"id":37659,"kind":"person","name":"Coughlin Timothy","position":1,"cik":"0001376043","reported_name":"COUGHLIN TIMOTHY","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-06-06T20:43:37.000Z","date":"2022-06-03","kind":"sale","acquired":false,"shares":1439,"price":22.81,"value":32823.59,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Required number of shares sold by the reporting person to cover tax obligations in connection with the vesting of 2,681 shares of Common Stock underlying RSUs granted to the reporting person on June 2, 2021. This sale was made pursuant to an irrevocable election by the reporting person to satisfy tax obligations through a \"sell to cover\" transaction and does not represent a discretionary trade by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents the weighted average sale price of the shares sold from $22.53 to $22.95 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote 2."}],"balance_after":57632,"source":{"system":"sec-edgar","filing":"0001209191-22-034541","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1434316/000120919122034541/doc4.xml","form_type":"4"}},{"id":2273416,"issuer":{"id":1562,"kind":"organization","name":"Travere Therapeutics, Inc.","symbol":"TVTX"},"owners":[{"id":37659,"kind":"person","name":"Coughlin Timothy","position":1,"cik":"0001376043","reported_name":"COUGHLIN TIMOTHY","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock option (right to buy)","published_at":"2022-05-13T00:22:39.000Z","date":"2022-05-11","kind":"grant","acquired":true,"shares":9000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Automatic equity grant under the Issuer's 2018 Equity Incentive Plan, as amended, pursuant to the non-employee director compensation program."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The equity award vests over a one year period."}],"balance_after":9000,"derivative":{"exercise_price":21.38,"exercise_date":"2023-05-11","expiration_date":"2032-05-10","underlying":"Common Stock","underlying_shares":9000},"source":{"system":"sec-edgar","filing":"0001209191-22-028690","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1438533/000120919122028690/doc4.xml","form_type":"4"}},{"id":2273415,"issuer":{"id":1562,"kind":"organization","name":"Travere Therapeutics, Inc.","symbol":"TVTX"},"owners":[{"id":37659,"kind":"person","name":"Coughlin Timothy","position":1,"cik":"0001376043","reported_name":"COUGHLIN TIMOTHY","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-05-13T00:22:39.000Z","date":"2022-05-11","kind":"grant","acquired":true,"shares":3000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Automatic equity grant under the Issuer's 2018 Equity Incentive Plan, as amended, pursuant to the non-employee director compensation program."},{"field":"shares","element":"transactionShares","label":"F2","text":"The equity award vests over a one year period."}],"balance_after":38000,"source":{"system":"sec-edgar","filing":"0001209191-22-028690","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1438533/000120919122028690/doc4.xml","form_type":"4"}},{"id":2288626,"issuer":{"id":7233,"kind":"organization","name":"aTYR PHARMA INC"},"owners":[{"id":37659,"kind":"person","name":"Coughlin Timothy","position":1,"cik":"0001376043","reported_name":"COUGHLIN TIMOTHY","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2022-04-28T23:42:58.000Z","date":"2022-04-26","kind":"grant","acquired":true,"shares":6000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (RSU) represents a contingent right to receive one share of the Issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The RSUs, granted pursuant to the Issuer's non-employee director compensation policy, vest in full on the earlier of (i) April 26, 2023 or (ii) the Issuer's 2023 Annual Meeting of Stockholders, subject to the Reporting Person's continued service on the Board of Directors."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The RSUs, granted pursuant to the Issuer's non-employee director compensation policy, vest in full on the earlier of (i) April 26, 2023 or (ii) the Issuer's 2023 Annual Meeting of Stockholders, subject to the Reporting Person's continued service on the Board of Directors."}],"balance_after":6000,"derivative":{"underlying":"Common Stock","underlying_shares":6000},"source":{"system":"sec-edgar","filing":"0001209191-22-026087","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1339970/000120919122026087/doc4.xml","form_type":"4"}},{"id":2680821,"issuer":{"id":5968,"kind":"organization","name":"FATE THERAPEUTICS INC"},"owners":[{"id":37659,"kind":"person","name":"Coughlin Timothy","position":1,"cik":"0001376043","reported_name":"COUGHLIN TIMOTHY","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2021-06-04T21:33:03.000Z","date":"2021-06-02","kind":"grant","acquired":true,"shares":4334,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares subject to this option shall vest and become exercisable on the earlier of (i) June 2, 2022 or (ii) the date of the Issuer's 2022 Annual Meeting of Stockholders, subject to the Reporting Person's continued service on the Issuer's Board of Directors."}],"balance_after":4334,"derivative":{"exercise_price":68.94,"expiration_date":"2031-06-01","underlying":"Common Stock","underlying_shares":4334},"source":{"system":"sec-edgar","filing":"0000899243-21-022090","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1434316/000089924321022090/doc4.xml","form_type":"4"}},{"id":2680820,"issuer":{"id":5968,"kind":"organization","name":"FATE THERAPEUTICS INC"},"owners":[{"id":37659,"kind":"person","name":"Coughlin Timothy","position":1,"cik":"0001376043","reported_name":"COUGHLIN TIMOTHY","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-06-04T21:33:03.000Z","date":"2021-06-02","kind":"grant","acquired":true,"shares":2681,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Award of restricted stock units that vest in full on the earlier of (i) June 2, 2022 or (ii) the date of the Issuer's 2022 Annual Meeting of Stockholders, subject to the Reporting Person's continued service on the Issuer's Board of Directors."}],"balance_after":59071,"source":{"system":"sec-edgar","filing":"0000899243-21-022090","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1434316/000089924321022090/doc4.xml","form_type":"4"}},{"id":2707802,"issuer":{"id":1562,"kind":"organization","name":"Travere Therapeutics, Inc.","symbol":"TVTX"},"owners":[{"id":37659,"kind":"person","name":"Coughlin Timothy","position":1,"cik":"0001376043","reported_name":"COUGHLIN TIMOTHY","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock option (right to buy)","published_at":"2021-05-19T01:30:36.000Z","date":"2021-05-14","kind":"grant","acquired":true,"shares":9000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Automatic equity grant under the Issuer's 2018 Equity Incentive Plan, as amended, pursuant to the non-employee director compensation program."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The equity award vests over a one year period."}],"balance_after":9000,"derivative":{"exercise_price":18.27,"exercise_date":"2022-05-14","expiration_date":"2031-05-13","underlying":"Common Stock","underlying_shares":9000},"source":{"system":"sec-edgar","filing":"0001209191-21-033855","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1438533/000120919121033855/doc4.xml","form_type":"4"}},{"id":2707801,"issuer":{"id":1562,"kind":"organization","name":"Travere Therapeutics, Inc.","symbol":"TVTX"},"owners":[{"id":37659,"kind":"person","name":"Coughlin Timothy","position":1,"cik":"0001376043","reported_name":"COUGHLIN TIMOTHY","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-05-19T01:30:36.000Z","date":"2021-05-14","kind":"grant","acquired":true,"shares":3000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Automatic equity grant under the Issuer's 2018 Equity Incentive Plan, as amended, pursuant to the non-employee director compensation program."},{"field":"shares","element":"transactionShares","label":"F2","text":"The equity award vests over a one year period."}],"balance_after":35000,"source":{"system":"sec-edgar","filing":"0001209191-21-033855","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1438533/000120919121033855/doc4.xml","form_type":"4"}},{"id":2735621,"issuer":{"id":7233,"kind":"organization","name":"aTYR PHARMA INC"},"owners":[{"id":37659,"kind":"person","name":"Coughlin Timothy","position":1,"cik":"0001376043","reported_name":"COUGHLIN TIMOTHY","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2021-04-30T00:06:39.000Z","date":"2021-04-28","kind":"grant","acquired":true,"shares":1428,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option, granted pursuant to the Issuer's non-employee director compensation policy, vests in full on the earlier of (i) April 28, 2022 or (ii) the Issuer's 2022 Annual Meeting of Stockholders, subject to the Reporting Person's continued service on the Board of Directors."}],"balance_after":1428,"derivative":{"exercise_price":4.21,"expiration_date":"2031-04-28","underlying":"Common Stock","underlying_shares":1428},"source":{"system":"sec-edgar","filing":"0001209191-21-029119","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1339970/000120919121029119/doc4.xml","form_type":"4"}},{"id":3142529,"issuer":{"id":1562,"kind":"organization","name":"Travere Therapeutics, Inc.","symbol":"TVTX"},"owners":[{"id":37659,"kind":"person","name":"Coughlin Timothy","position":1,"cik":"0001376043","reported_name":"COUGHLIN TIMOTHY","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Employee stock option (right to buy)","published_at":"2020-05-20T00:00:16.000Z","date":"2020-05-15","kind":"grant","acquired":true,"shares":9000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":9000,"derivative":{"exercise_price":15.43,"exercise_date":"2021-05-15","expiration_date":"2030-05-14","underlying":"Common Stock","underlying_shares":9000},"source":{"system":"sec-edgar","filing":"0001209191-20-030746","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1438533/000120919120030746/doc4.xml","form_type":"4"}},{"id":3142528,"issuer":{"id":1562,"kind":"organization","name":"Travere Therapeutics, Inc.","symbol":"TVTX"},"owners":[{"id":37659,"kind":"person","name":"Coughlin Timothy","position":1,"cik":"0001376043","reported_name":"COUGHLIN TIMOTHY","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-05-20T00:00:16.000Z","date":"2020-05-15","kind":"grant","acquired":true,"shares":3000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":32000,"source":{"system":"sec-edgar","filing":"0001209191-20-030746","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1438533/000120919120030746/doc4.xml","form_type":"4"}},{"id":3156058,"issuer":{"id":7233,"kind":"organization","name":"aTYR PHARMA INC"},"owners":[{"id":37659,"kind":"person","name":"Coughlin Timothy","position":1,"cik":"0001376043","reported_name":"COUGHLIN TIMOTHY","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2020-05-08T20:53:12.000Z","date":"2020-05-06","kind":"grant","acquired":true,"shares":1428,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option, granted pursuant to the Issuer's non-employee director compensation policy, vests in full on the earlier of (i) May 6, 2021 or (ii) the Issuer's 2021 Annual Meeting of Stockholders, subject to the Reporting Person's continued service on the Board of Directors."}],"balance_after":1428,"derivative":{"exercise_price":3.65,"expiration_date":"2030-05-06","underlying":"Common Stock","underlying_shares":1428},"source":{"system":"sec-edgar","filing":"0001209191-20-027960","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1339970/000120919120027960/doc4.xml","form_type":"4"}},{"id":3161018,"issuer":{"id":5968,"kind":"organization","name":"FATE THERAPEUTICS INC"},"owners":[{"id":37659,"kind":"person","name":"Coughlin Timothy","position":1,"cik":"0001376043","reported_name":"COUGHLIN TIMOTHY","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2020-05-05T20:11:13.000Z","date":"2020-05-01","kind":"grant","acquired":true,"shares":16000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Not applicable."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to this option shall vest and become exercisable on the earlier of (i) May 1, 2021 or (ii) the date of the Issuer's 2021 Annual Meeting of Stockholders, subject to the recipient's continued service on the Issuer's Board of Directors."}],"balance_after":16000,"derivative":{"exercise_price":26.59,"expiration_date":"2030-05-01","underlying":"Common Stock","underlying_shares":16000},"source":{"system":"sec-edgar","filing":"0001209191-20-027069","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1434316/000120919120027069/doc4.xml","form_type":"4"}},{"id":3531432,"issuer":{"id":1562,"kind":"organization","name":"Travere Therapeutics, Inc.","symbol":"TVTX"},"owners":[{"id":37659,"kind":"person","name":"Coughlin Timothy","position":1,"cik":"0001376043","reported_name":"Coughlin Timothy P","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Employee stock option (right to buy)","published_at":"2019-05-11T00:34:25.000Z","date":"2019-05-08","kind":"grant","acquired":true,"shares":8000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":8000,"derivative":{"exercise_price":17.94,"exercise_date":"2020-05-08","expiration_date":"2029-05-07","underlying":"Common Stock","underlying_shares":8000},"source":{"system":"sec-edgar","filing":"0001209191-19-029153","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1438533/000120919119029153/doc4.xml","form_type":"4"}},{"id":3531431,"issuer":{"id":1562,"kind":"organization","name":"Travere Therapeutics, Inc.","symbol":"TVTX"},"owners":[{"id":37659,"kind":"person","name":"Coughlin Timothy","position":1,"cik":"0001376043","reported_name":"Coughlin Timothy P","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-05-11T00:34:25.000Z","date":"2019-05-08","kind":"grant","acquired":true,"shares":2000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":29000,"source":{"system":"sec-edgar","filing":"0001209191-19-029153","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1438533/000120919119029153/doc4.xml","form_type":"4"}},{"id":3531214,"issuer":{"id":7233,"kind":"organization","name":"aTYR PHARMA INC"},"owners":[{"id":37659,"kind":"person","name":"Coughlin Timothy","position":1,"cik":"0001376043","reported_name":"Coughlin Timothy P","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2019-05-10T21:06:19.000Z","date":"2019-05-08","kind":"grant","acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option, granted pursuant to the Issuer's non-employee director compensation policy, vests in full on the earlier of (i) May 8, 2020 or (ii) the Issuer's 2020 Annual Meeting of Stockholders, subject to the Reporting Person's continued service on the Board of Directors."}],"balance_after":20000,"derivative":{"exercise_price":0.5834,"expiration_date":"2029-05-08","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001209191-19-029011","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1339970/000120919119029011/doc4.xml","form_type":"4"}},{"id":3536420,"issuer":{"id":5968,"kind":"organization","name":"FATE THERAPEUTICS INC"},"owners":[{"id":37659,"kind":"person","name":"Coughlin Timothy","position":1,"cik":"0001376043","reported_name":"Coughlin Timothy P","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2019-05-07T20:03:50.000Z","date":"2019-05-03","kind":"grant","acquired":true,"shares":16000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Not applicable."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to this option shall vest and become exercisable on the earlier of (i) May 3, 2020 or (ii) the date of the Issuer's 2020 Annual Meeting of Stockholders, subject to the recipient's continued service on the Issuer's Board of Directors."}],"balance_after":16000,"derivative":{"exercise_price":17.15,"expiration_date":"2029-05-03","underlying":"Common Stock","underlying_shares":16000},"source":{"system":"sec-edgar","filing":"0001209191-19-027945","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1434316/000120919119027945/doc4.xml","form_type":"4"}},{"id":3927568,"issuer":{"id":7233,"kind":"organization","name":"aTYR PHARMA INC"},"owners":[{"id":37659,"kind":"person","name":"Coughlin Timothy","position":1,"cik":"0001376043","reported_name":"Coughlin Timothy P","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2018-05-17T20:23:41.000Z","date":"2018-05-15","kind":"grant","acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option, granted pursuant to the Issuer's non-employee director compensation policy, vests in full on the earlier of (i) May 15, 2019 or (ii) the Issuer's 2019 Annual Meeting of Stockholders, subject to the Reporting Person's continued service on the Board of Directors."}],"balance_after":20000,"derivative":{"exercise_price":1.35,"expiration_date":"2028-05-15","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001209191-18-030907","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1339970/000120919118030907/doc4.xml","form_type":"4"}},{"id":3936949,"issuer":{"id":1562,"kind":"organization","name":"Travere Therapeutics, Inc.","symbol":"TVTX"},"owners":[{"id":37659,"kind":"person","name":"Coughlin Timothy","position":1,"cik":"0001376043","reported_name":"Coughlin Timothy P","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2018-05-12T01:09:54.000Z","date":"2018-05-09","kind":"grant","acquired":true,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option shall vest in 4 equal quarterly installments following the date of grant."}],"balance_after":10000,"derivative":{"exercise_price":26.52,"expiration_date":"2028-05-08","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001209191-18-029723","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1438533/000120919118029723/doc4.xml","form_type":"4"}},{"id":3936948,"issuer":{"id":1562,"kind":"organization","name":"Travere Therapeutics, Inc.","symbol":"TVTX"},"owners":[{"id":37659,"kind":"person","name":"Coughlin Timothy","position":1,"cik":"0001376043","reported_name":"Coughlin Timothy P","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-05-12T01:09:54.000Z","date":"2018-05-09","kind":"grant","acquired":true,"shares":2500,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":27000,"source":{"system":"sec-edgar","filing":"0001209191-18-029723","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1438533/000120919118029723/doc4.xml","form_type":"4"}},{"id":3945499,"issuer":{"id":5968,"kind":"organization","name":"FATE THERAPEUTICS INC"},"owners":[{"id":37659,"kind":"person","name":"Coughlin Timothy","position":1,"cik":"0001376043","reported_name":"Coughlin Timothy P","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2018-05-04T20:16:46.000Z","date":"2018-05-02","kind":"grant","acquired":true,"shares":16000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Not applicable."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to this option shall vest and become exercisable on the earlier of (i) May 2, 2019 or (ii) the date of the 2019 Annual Meeting of Stockholders, subject to the recipient's continued service on the Issuer's Board of Directors."}],"balance_after":16000,"derivative":{"exercise_price":9.78,"expiration_date":"2028-05-02","underlying":"Common Stock","underlying_shares":16000},"source":{"system":"sec-edgar","filing":"0001209191-18-028099","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1434316/000120919118028099/doc4.xml","form_type":"4"}},{"id":4313492,"issuer":{"id":1562,"kind":"organization","name":"Travere Therapeutics, Inc.","symbol":"TVTX"},"owners":[{"id":37659,"kind":"person","name":"Coughlin Timothy","position":1,"cik":"0001376043","reported_name":"Coughlin Timothy P","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2017-05-18T22:17:10.000Z","date":"2017-05-17","kind":"grant","acquired":true,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option shall vest in 4 equal quarterly installments following the date of grant."}],"balance_after":10000,"derivative":{"exercise_price":17.44,"expiration_date":"2027-05-16","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001209191-17-033720","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1438533/000120919117033720/doc4.xml","form_type":"4"}},{"id":4313491,"issuer":{"id":1562,"kind":"organization","name":"Travere Therapeutics, Inc.","symbol":"TVTX"},"owners":[{"id":37659,"kind":"person","name":"Coughlin Timothy","position":1,"cik":"0001376043","reported_name":"Coughlin Timothy P","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-05-18T22:17:10.000Z","date":"2017-05-17","kind":"grant","acquired":true,"shares":2500,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":24500,"source":{"system":"sec-edgar","filing":"0001209191-17-033720","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1438533/000120919117033720/doc4.xml","form_type":"4"}},{"id":4324414,"issuer":{"id":7233,"kind":"organization","name":"aTYR PHARMA INC"},"owners":[{"id":37659,"kind":"person","name":"Coughlin Timothy","position":1,"cik":"0001376043","reported_name":"Coughlin Timothy P","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2017-05-11T22:54:18.000Z","date":"2017-05-09","kind":"grant","acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to this option shall vest and become exercisable on the earlier of (i) May 09, 2018 or (ii) the date of the 2018 Annual Meeting of Stockholders, subject to the recipient's continued service on the Issuer's Board of Directors."}],"balance_after":20000,"derivative":{"exercise_price":3.15,"expiration_date":"2027-05-09","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001209191-17-031635","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1339970/000120919117031635/doc4.xml","form_type":"4"}},{"id":4333231,"issuer":{"id":5968,"kind":"organization","name":"FATE THERAPEUTICS INC"},"owners":[{"id":37659,"kind":"person","name":"Coughlin Timothy","position":1,"cik":"0001376043","reported_name":"Coughlin Timothy P","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2017-05-04T15:56:54.000Z","date":"2017-05-02","kind":"grant","acquired":true,"shares":25000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Not applicable."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to this option shall vest and become exercisable on the earlier of (i) May 2, 2018 or (ii) the date of the 2018 Annual Meeting of Stockholders, subject to the recipient's continued service on the Issuer's Board of Directors."}],"balance_after":25000,"derivative":{"exercise_price":4.73,"expiration_date":"2027-05-01","underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001209191-17-029928","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1434316/000120919117029928/doc4.xml","form_type":"4"}},{"id":4355202,"issuer":{"id":7233,"kind":"organization","name":"aTYR PHARMA INC"},"owners":[{"id":37659,"kind":"person","name":"Coughlin Timothy","position":1,"cik":"0001376043","reported_name":"Coughlin Timothy P","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2017-04-10T21:29:00.000Z","date":"2017-04-07","kind":"grant","acquired":true,"shares":32000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to this option shall vest and become exercisable in 36 equal monthly installments beginning May 7, 2017, such that this option will fully exercisable on April 7, 2020, subject to the recipient's continued service on the Issuer's Board of Directors."}],"balance_after":32000,"derivative":{"exercise_price":3.25,"expiration_date":"2027-04-07","underlying":"Common Stock","underlying_shares":32000},"source":{"system":"sec-edgar","filing":"0001209191-17-026450","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1339970/000120919117026450/doc4.xml","form_type":"4"}},{"id":4462309,"issuer":{"id":2655,"kind":"organization","name":"NEUROCRINE BIOSCIENCES INC","symbol":"NBIX"},"owners":[{"id":37659,"kind":"person","name":"Coughlin Timothy","position":1,"cik":"0001376043","reported_name":"Coughlin Timothy P","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2017-02-09T00:39:04.000Z","date":"2017-02-06","kind":"sale","acquired":false,"shares":963,"price":43.14,"value":41543.82,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Sale of 963 shares of common stock issued upon vesting of 2550 restricted stock units to cover withholding taxes with the balance of the shares (1587) maintained by the Reporting Person; the disposition reported in this Form 4 was effected by a broker pursuant to instructions set forth in a Rule 10b5-1 trading plan adopted by the Reporting Person at least 90 days prior to the transaction date in Box 3 above. Additionally, Issuer policy restricts the Reporting Person from amending, canceling, suspending or otherwise modifying any 10b5-1 trading plan subsequent to adoption of the plan."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents a weighted average sales price per share. These shares were sold in multiple transactions at prices ranging from $42.69 to $43.37. The Reporting Person has provided to the issuer, and will provide to any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range."}],"balance_after":137961,"source":{"system":"sec-edgar","filing":"0001209191-17-008909","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/914475/000120919117008909/doc4.xml","form_type":"4"}},{"id":4466885,"issuer":{"id":2655,"kind":"organization","name":"NEUROCRINE BIOSCIENCES INC","symbol":"NBIX"},"owners":[{"id":37659,"kind":"person","name":"Coughlin Timothy","position":1,"cik":"0001376043","reported_name":"Coughlin Timothy P","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2017-02-07T00:19:13.000Z","date":"2017-02-03","kind":"sale","acquired":false,"shares":1500,"price":42.55,"value":63825.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Sale of 1,500 shares of common stock issued upon vesting of 3,000 restricted stock units on February 3, 2017 to cover payroll and withholding taxes, with the balance of the shares (1,500) maintained by the Reporting Person; the disposition reported in this Form 4 was effected by a broker pursuant to instructions set forth in a Rule 10b5-1 trading plan adopted by the Reporting Person at least 90 days prior to the transaction date in Box 3 above. Additionally, Issuer policy restricts the Reporting Person from amending, canceling, suspending or otherwise modifying any 10b5-1 trading plan subsequent to adoption of the plan."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents a weighted average sales price per share. These shares were sold in multiple transactions at prices ranging from $41.80 to $43.29. The Reporting Person has provided to the issuer, and will provide to any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range."}],"balance_after":136324,"source":{"system":"sec-edgar","filing":"0001209191-17-008136","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/914475/000120919117008136/doc4.xml","form_type":"4"}},{"id":4488898,"issuer":{"id":2655,"kind":"organization","name":"NEUROCRINE BIOSCIENCES INC","symbol":"NBIX"},"owners":[{"id":37659,"kind":"person","name":"Coughlin Timothy","position":1,"cik":"0001376043","reported_name":"Coughlin Timothy P","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2017-01-18T23:45:06.000Z","date":"2017-01-17","kind":"sale","acquired":false,"shares":1750,"price":40.65,"value":71137.5,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Sale of 1,750 shares of common stock issued upon vesting of 3,500 restricted stock units on January 17, 2017 to cover payroll and withholding taxes, with the balance of the shares (1,750) maintained by the Reporting Person; the disposition reported in this Form 4 was effected by a broker pursuant to instructions set forth in a Rule 10b5-1 trading plan adopted by the Reporting Person at least 90 days prior to the transaction date in Box 3 above. Additionally, Issuer policy restricts the Reporting Person from amending, canceling, suspending or otherwise modifying any 10b5-1 trading plan subsequent to adoption of the plan."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents a weighted average sales price per share. These shares were sold in multiple transactions at prices ranging from $39.91 to $41.73. The Reporting Person has provided to the issuer, and will provide to any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range."}],"balance_after":134824,"source":{"system":"sec-edgar","filing":"0001209191-17-004305","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/914475/000120919117004305/doc4.xml","form_type":"4"}},{"id":4492569,"issuer":{"id":2655,"kind":"organization","name":"NEUROCRINE BIOSCIENCES INC","symbol":"NBIX"},"owners":[{"id":37659,"kind":"person","name":"Coughlin Timothy","position":1,"cik":"0001376043","reported_name":"Coughlin Timothy P","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2017-01-12T23:59:50.000Z","date":"2017-01-10","kind":"sale","acquired":false,"shares":1750,"price":43.37,"value":75897.5,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Sale of 1,750 shares of common stock issued upon vesting of 3,500 restricted stock units on January 10, 2017 to cover payroll and withholding taxes, with the balance of the shares (1,750) maintained by the Reporting Person; the disposition reported in this Form 4 was effected by a broker pursuant to instructions set forth in a Rule 10b5-1 trading plan adopted by the Reporting Person at least 90 days prior to the transaction date in Box 3 above. Additionally, Issuer policy restricts the Reporting Person from amending, canceling, suspending or otherwise modifying any 10b5-1 trading plan subsequent to adoption of the plan."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents a weighted average sales price per share. These shares were sold in multiple transactions at prices ranging from $42.50 to $45.49. The Reporting Person has provided to the issuer, and will provide to any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range."}],"balance_after":133124,"source":{"system":"sec-edgar","filing":"0001209191-17-003584","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/914475/000120919117003584/doc4.xml","form_type":"4"}},{"id":4541044,"issuer":{"id":5968,"kind":"organization","name":"FATE THERAPEUTICS INC"},"owners":[{"id":37659,"kind":"person","name":"Coughlin Timothy","position":1,"cik":"0001376043","reported_name":"Coughlin Timothy P","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2016-11-28T20:42:53.000Z","date":"2016-11-23","kind":"purchase","acquired":true,"shares":56390,"price":2.66,"value":149997.4,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares acquired in a private placement pursuant to the Securities Purchase Agreement dated November 21, 2016 by and among the issuer and the purchasers named therein."}],"balance_after":56390,"source":{"system":"sec-edgar","filing":"0001209191-16-152153","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1434316/000120919116152153/doc4.xml","form_type":"4"}}]}